The aim of this study was to determine the susceptibility of Lactobacillus bacteria to selected coccidiostats. Seventy-five Lactobacillus isolates obtained from chickens were classified by MALDI-TOF mass spectrometry and 16S rDNA restriction analysis into seven species, among which L. salivarius (33%) and L. johnsonii (24%) were dominant. Susceptibility of lactobacilli to coccidiostats was determined by broth microdilution method. The ranges of minimum inhibitory concentrations (MICs) were 0.5-≥128 µg/ml for monensin, 0.125-8 µg/ml for salinomycin, ≤0.03-2 µg/ml for lasalocid A, and 4-16 µg/ml for robenidine. Coccidiostats in low concentrations inhibited in vitro growth of most lactobacilli and therefore there is a high probability that administration of this drugs to chickens would reduce the number of lactobacilli in the gut.
doi: 10.1292/jvms. systematics of Lactobacillus spp. as well as in bacterial resistance, so that research from the 20th century must be updated.
The Lactobacillus bacteria used in this study were isolated from fresh feces or cloacae of 20 healthy chickens (14 broilers and 6 Green-legged Partridge hens) from 6 large-scale poultry farms located in different parts of Poland. According to information from veterinarians supervising the flocks, the birds were vaccinated against coccidiosis and were not administered coccidiostats. Lactobacilli were cultured on deMan Rogosa Sharpe medium (MRS, BTL, Łódź, Poland) at 37°C for 48 hr in 5% CO 2 . Pure cultures supplemented with 20% glycerol were stored at −80°C until further analysis.
Lactobacilli were identified to species level by MALDI-TOF mass spectrometry (MS) using a direct on-plate extraction method and an UltrafleXtreme MALDI TOF mass spectrometer (Bruker, Germany) [7] . In the case of ambiguous results, 16S rDNA restriction analysis was additionally used, as previously described [8] .
The antibiotic susceptibility of all bacterial isolates was determined by the broth microdilution method using LSM medium in accordance with ISO 10932|IDF 223:2010 [12] . Coccidiostats, i.e. monensin, salinomycin, lasalocid A and robenidine, were obtained from Sigma-Aldrich (Poland). Stock solutions (10 mg/ml) were prepared by dissolving the drugs in methanol (monensin and salinomycin) or in DMSO (robenidine). The ready-to-use lasalocid A solution had a concentration of 100 µg/ml.
Prior to antimicrobial susceptibility testing, cultures were streaked on LSM agar and incubated for about 20 hr at 37°C in 5% CO 2 . Inocula were prepared by suspending bacteria in 0.85% NaCl to the turbidity of a 0.8 McFarland standard using DENSI-LA-METER II (Erba, Czech Republic). Microdilution plates were inoculated with 50 µl of a 1:500-diluted (in LSM broth) inoculum and 50 µl of the appropriate antibiotic concentration. After the plates had been incubated at 37°C in 5% CO 2 for 48 hr, the minimum inhibitory concentration (MIC) values were read as the lowest concentration of the antimicrobial agent at which visible growth was inhibited.
A total of 75 isolates were classified by MALDI-TOF MS as bacteria of the genus Lactobacillus, with a Biotyper log (score) equal to or greater than 1.70. Eighteen isolates for which MALDI-TOF MS identification results were ambiguous, i.e. L. johnsonii/L. gasseri, were further identified by 16S rDNA restriction analysis using the MseI restriction enzyme. The analysis showed that all these isolates belonged to the species L. johnsonii. Finally, the Lactobacillus isolates were classified into seven species:
The range of MIC values was different for individual coccidiostats, i.e.: 0.5-≥128 µg/ml for monensin, 0.125-8 µg/ml for salinomycin, 4-16 µg/ml for robenidine and ≤0.03-2 µg/ml for lasalocid A. In contrast to the ionophores, robenidine had a narrow range of MIC values, which in 99% of the isolates were 4 or 8 µg/ml. The widest range of MIC values was recorded for monensin; the results may indicate that L. reuteri isolates are less sensitive to this ionophore antibiotic (MIC 8-32 µg/ml) than other Lactobacillus species (Table 1) .
The coccidiostat MIC values obtained are partly consistent with the results reported by other authors. Rada et al. [18] noted growth inhibition of all Lactobacillus isolates used in their study (mainly L. fermentum, n=14) at a 10 µg/ml concentration of monensin, lasalocid, salinomycin and narasin. In a later study, involving four Lactobacillus isolates, the same research team determined the MICs for the ionophores using MRS broth. They ranged from 0.4 to 5 µg/ml for monensin, narasin, lasalocid, salinomycin and maduramicin [16] . We obtained similar results for salinomycin and lasalocide, where MICs reached 8 and 2 µg/ ml, respectively. The range of MIC values for monensin in the present study was much wider (0.5-≥128 µg/ml) than that observed by the Czech team, but reliable comparison of the results is not possible due to the very small number of strains used in the Czech study. A wide range of monensin MICs, i.e. 0.5-32 µg/ml, has also been noted by Aarestrup et al. [1] for E. faecium isolates from Scandinavian broiler and pig farms. According to the cut-off point proposed by these authors (16 µg/ml), as much as 34.7% of the Lactobacillus isolates tested could be classifies as monensin resistant. Increased monensin MICs observed in this work may be due to bacterial extracellular polysaccharides (the glycocalyx) that exclude ionophores from the cell membrane [23] . As the production of extracellular polysaccharide by lactobacilli is strain-specific, some strains may be less susceptible to monensin than others [15] . The sensitivity of Gram-positive bacteria colonizing the rumen to monensin has been shown to decrease following repeated exposure to this ionophore (change in MIC value from 4 to 128 µg/ml). Moreover, this effect was found to be reversible, as upon consecutive subculturing, monensin MICs returned to the baseline, or one dilution above, for the monensin-adapted strains [4, 26] . Monensin in low concentrations, i.e. 1-4 µg/ml, inhibited also lactic acid bacteria used as dairy starter cultures and the strain found to be most susceptible to monensin was Lactobacillus acidophilus La-5 (MIC=1 µg/ml) [11] . Dennis et al. [9] have shown that even such low doses of monensin and lasalocid as 0.38-3.0 µg/ml inhibit most lactate-producing rumen bacteria, including Lactobacillus ruminis.
The robenidine MIC values presented in this study (4-16 µg/ml) deviate significantly from the results reported by Rada et al. [21] , who observed growth inhibition of two Lactobacillus isolates (L. casei and L. salivarius from chicken) at much higher concentrations of this non-ionophore coccidiostat, i.e. 90-110 µg/ml. For monensin, low MIC values of 2 µg/ml were noted for the same strains. Our results are more consistent with the data provided by the Panel on Additives and Products or Substances in Animal Feed [10] , according to which lactobacilli are inhibited by robenidine at concentrations of 8-32 µg/ml. Similar MIC ranges of this drug were obtained for other Gram-positive bacteria, including streptococci (8-32 µg/ml), enterococci and staphylococci (8-16 µg/ml), and clostridia (1-8 µg/ml) [10] .
No clear bimodal distribution of MIC values that might indicate acquired resistance in the lactobacilli was observed for any antimicrobial substance used in this study. This is in line with the results of many studies confirming the high susceptibility of Gram-positive bacteria (Enterococcus spp., C. perfringens, P. acidilactici and S. aureus) to coccidiostats [1, 2, 6, 17, 27] . Genes responsible for ionophore resistance in bacteria have not been identified [23] . However, some studies report the presence of ionophore resistance (mainly to salinomycin, less often to narasin and monensin) in lactic acid bacteria other that Lactobacillus spp. [1, 3, 28, 29] . Butaye et al. [3] noted bimodal distribution of narasin MICs indicating acquired resistance and cross-resistance to salinomycin and narasin in enterococci from Belgian farms.
It is worth noting that the in vitro inhibitory effect of coccidiostats on the growth of Lactobacillus bacteria has not always been reflected in vivo. Rada and Mauronek [20] showed that administration of maduramicin and monensin to newly hatched chickens at 5 and 100 mg per kg of diet, respectively, did not eliminate lactobacilli. They were still present in high numbers in the crop and caecal contents of chickens 5 days after inoculation with L. salivarius strain 51R. In another experiment, the same authors [19] found that the addition of monensin to the feed (100 mg/ml) significantly lowered the number of lactobacilli and decreased the concentrations of organic acids in the crop contents. Increased intestinal pH was accompanied by proliferation of coliforms and enterococci. The lactobacilli counts returned to the pretreatment level within 5 days of monensin administration, but the counts of coliforms and enterococci remained elevated. Changes in the composition of chicken microflora have also been observed following the administration of robenidine at 44 mg/kg. The coccidiostat delayed colonization with lactobacilli and depression of E. coli counts during the first two weeks of life [10] .
In summary, coccidiostats such as monensin, salinomycin, lasalocid and robenidine in low concentrations inhibit in vitro growth of most Lactobacillus bacteria from chickens. There is therefore a probability that administration of this type of drugs to chickens would reduce the number of lactobacilli in the gut, which could translate into a microbial imbalance of the mucous membranes. Therefore, it seems advisable to correlate coccidiostatic therapy in poultry with the administration of microbial feed additives, i.e. probiotic Lactobacillus strains. However, it should be emphasized that in vitro results do not always translate into in vivo effects, and confirmation of the inhibitory effect of coccidiostats on intestinal lactobacilli in chickens requires further testing using animal models. Data derived from this study may contribute to the establishment of standards for categorization of susceptible and resistant strains of Lactobacillus genus in reference to coccidiostats. 
